Aptorum Group Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Aptorum Group Stock Summary

Aptorum Group competes with Surrozen, Unicycive Therapeutics, Armata Pharmaceuticals, AIM ImmunoTech, and Biocardia. Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Aptorum Group Key Financial Ratios

Aptorum Group Key Balance Sheet Accounts

Aptorum Group Key Income Statement Accounts

Aptorum Group Key Cash Accounts

Aptorum Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aptorum Group's current stock value. Our valuation model uses many indicators to compare Aptorum Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aptorum Group competition to find correlations between indicators driving Aptorum Group's intrinsic value. More Info.Aptorum Group Ltd is rated second in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, Aptorum Group's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aptorum Group by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Aptorum Group Systematic Risk

Today, most investors in Aptorum Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aptorum Group's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aptorum Group growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Aptorum Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aptorum Group Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aptorum Group Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Aptorum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aptorum Group's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptorum Group Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.